Active Recombinant Human TNFRSF9 Protein, His & Avi-tagged, Biotinylated
Cat.No. : | TNFRSF9-551H |
Product Overview : | Biotinylated Recombinant Human TNFRSF9 Protein (Leu 24 - Gln 186) (NP_001552.2), fused with an Avi tag at the C-terminus, followed by a polyhistidine tag, was expressed in HEK293. |
- Specification
- Gene Information
- Related Products
- Download
Source : | HEK293 |
Species : | Human |
Tag : | His & Avi |
Predicted N Terminal : | Leu 24 |
Form : | Lyophilized from sterile PBS, pH7.4, 10% trehalose. |
Bio-activity : | Measured by its binding ability in a functional ELISA. Immobilized Human 4?1BB Ligand, Fc Tag at 2μg/mL (100 μL/well) can bind Biotinylated Human 4-1BB with a linear range of 2-31 ng/mL. |
Molecular Mass : | Recombinant Human TNFRSF9 Protein has a calculated MW of 19.9 kDa. The protein migrates as 35-40 kDa on a SDS-PAGE gel under reducing (R) condition due to glycosylation. |
Protein length : | Leu 24 - Gln 186 |
Endotoxin : | Less than 1.0 EU per μg by the LAL method. |
Purity : | >95% as determined by SDS-PAGE. |
Stability : | Samples are stable for up to twelve months from date of receipt at -70ºC. |
Storage : | Store it under sterile conditions at -20ºC~-70ºC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles. |
Reconstitution : | It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 ug/ul. Centrifuge the vial at 4℃ before opening to recover the entire contents. |
Gene Name : | TNFRSF9 tumor necrosis factor receptor superfamily, member 9 [ Homo sapiens ] |
Official Symbol : | TNFRSF9 |
Synonyms : | TNFRSF9; tumor necrosis factor receptor superfamily, member 9; ILA; tumor necrosis factor receptor superfamily member 9; 4 1BB; CD137; CD137 antigen; T cell antigen ILA; T-cell antigen ILA; 4-1BB ligand receptor; homolog of mouse 4-1BB; receptor protein 4-1BB; T-cell antigen 4-1BB homolog; induced by lymphocyte activation (ILA); interleukin-activated receptor, homolog of mouse Ly63; 4-1BB; CDw137; MGC2172; FLJ43501; |
Gene ID : | 3604 |
mRNA Refseq : | NM_001561 |
Protein Refseq : | NP_001552 |
MIM : | 602250 |
UniProt ID : | Q07011 |
Chromosome Location : | 1p36 |
Pathway : | Cytokine-cytokine receptor interaction, organism-specific biosystem; Cytokine-cytokine receptor interaction, conserved biosystem; Downstream signaling in naive CD8+ T cells, organism-specific biosystem; |
Function : | binding; receptor activity; |
Products Types
◆ Recombinant Protein | ||
TNFRSF9-4684R | Recombinant Rhesus Macaque TNFRSF9 Protein, His (Fc)-Avi-tagged | +Inquiry |
TNFRSF9-583M | Recombinant Mouse TNFRSF9 Protein, Fc-tagged | +Inquiry |
TNFRSF9-551R | Active Recombinant Rhesus TNFRSF9 Protein, Fc-tagged | +Inquiry |
TNFRSF9-329H | Recombinant Human TNFRSF9 Protein (Met1-Gln186), His-tagged, Biotinylated | +Inquiry |
TNFRSF9-315H | Recombinant Human TNFRSF9 Protein (ECD), Fc-His-tagged(C-ter) | +Inquiry |
◆ Lysates | ||
TNFRSF9-928CCL | Recombinant Canine TNFRSF9 cell lysate | +Inquiry |
TNFRSF9-1792MCL | Recombinant Mouse TNFRSF9 cell lysate | +Inquiry |
TNFRSF9-2162HCL | Recombinant Human TNFRSF9 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionStudies have found that abnormal expression levels of TNFRSF9 may be associated with certain tumors, autoimmune diseases, and inflammatory diseases.
It has a variety of associations with other proteins and cytokines. For example, it may interact with the NF-kB signaling pathway to regulate the inflammatory response, and it may also interact with apoptosis-related proteins to regulate the apoptosis process.
TNFRSF9 mainly plays an important role in the immune system, as an activating signaling molecule, it is able to stimulate the activation, proliferation and survival of T cells and NK cells.
Inhibitors or activators targeting TNFRSF9 may have potential applications for the treatment of certain tumors, autoimmune diseases, and inflammatory diseases.
The extracellular domain of TNFRSF9 can bind to its ligand, such as 4-1BBL, to initiate signal transduction, which in turn activates downstream signaling pathways.
TNFRSF9 has some potential in tumor immunotherapy. Several antibody drugs have been developed to use the stimulating effects of TNFRSF9 to enhance the activity of immune cells to fight tumors.
Customer Reviews (3)
Write a reviewGood heat resistance, long time treatment at high temperature, still has activity.
The results obtained by SDS-PAGE or Western blot analysis were good.
The purity is good, and the experimental results obtained are accurate.
Ask a Question for All TNFRSF9 Products
Required fields are marked with *
My Review for All TNFRSF9 Products
Required fields are marked with *
Inquiry Basket